Literature DB >> 31261253

Mesalazine and Nephrolithiasis: Leave No Stone Unturned.

Melek Simsek1, Nanne K H de Boer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31261253     DOI： 10.14309/ajg.0000000000000311

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  2 in total

1.  Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study.

Authors:  Jake Herbert; Emily Teeter; Landen Shane Burstiner; Ralfi Doka; Amor Royer; Anna H Owings; Julia Liu; Sarah C Glover; Pegah Hosseini-Carroll
Journal:  BMC Urol       Date:  2022-01-04       Impact factor: 2.264

2.  Prevalence of Renal Stones Among Patients With Inflammatory Bowel Disease in Saudi Arabia.

Authors:  Mahmoud Mosli; Abdulrahman M Alzahrani; Rafeef A Bahafzalla; Tala A Gazzaz; Rahaf M Slaghour; Ghidah Z Altabsh; Sarah B Aljadani; Razan N Alturkestani; Sondos S Hussein; Abdullah Kashgary; Omar I Saadah
Journal:  Cureus       Date:  2021-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.